- Positive Expiratory Pressure (PEP)
- Oscillatory Positive Expiratory Pressure (OPEP)
- High Frequency Chest Wall Compression
- Intrapulmonary Percussive Ventilation flutter
- Incentive spirometry
- Mechanical Cough Assist
Airway Clearance Devices Market size was valued at USD 589.6 million in 2023 and is expected to reach USD 796.2 million by 2030, at a CAGR of 7.4% from 2024-2030 owing to an increase in the prevalence of respiratory diseases all over the world. Rising incidences of respiratory diseases such as COPD, asthma, and other lung infections, and prevalence of diseases such as cystic fibrosis, chronic diffuse bronchiectasis, neuromuscular diseases and immotile ciliary dysfunction/primary ciliary dyskinesia. Airway clearance devices are used to clear out any infections present in the respiratory tract and make it clear without any obstacles. Additionally, due to the limitations of the earlier practice of traditional chest physiotherapy, high patient compliance to the respiratory clearance devices, lower costs and increased awareness are expected to enhance the sales of the market.
This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global airway clearance devices market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities).
Study Period
2024-2030Base Year
2023CAGR
7.4%Largest Market
North-AmericaFastest Growing Market
Asia-Pacific
Increase in the prevalence of respiratory diseases like asthma, COPD, chronic diffuse bronchiectasis, and other respiratory diseases is a key factor drive the global airway clearance devices market. According to World Health Organization, approximately about 65 million people are suffering from COPD globally and it was the third leading reason of deaths all over the world. Increase in awareness regarding the devices, the raise in funding for the R&D activities by public and private sectors, advantages of using these devices over conventional chest physiotherapy are anticipated to propel the global artificial joints market over the forecast years
By Product Type
By End-User
The airway clearance devices market size was valued at USD 589.6 million in 2023
The airway clearance devices market key players are: Hill-Rom Holdings, Inc. Aptalis Pharma US,Inc. Thayer Medical Electromed Inc. Breas Medical General Physiotherapy, Inc.
The airway clearance devices market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.